- Home
- ADBE vs ABT Comparison
ADBE vs ABT Comparison
Compare ADBE & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADBE
- ABT
- Stock Information
- Founded
- ADBE 1982
- ABT 1888
- Country
- ADBE United States
- ABT United States
- Employees
- ADBE N/A
- ABT N/A
- Industry
- ADBE Computer Software: Prepackaged Software
- ABT Medical/Dental Instruments
- Sector
- ADBE Technology
- ABT Health Care
- Exchange
- ADBE Nasdaq
- ABT Nasdaq
- Market Cap
- ADBE 164.4B
- ABT 221.0B
- IPO Year
- ADBE 1986
- ABT N/A
- Fundamental
- Price
- ADBE $385.71
- ABT $130.82
- Analyst Decision
- ADBE Buy
- ABT Buy
- Analyst Count
- ADBE 24
- ABT 18
- Target Price
- ADBE $549.55
- ABT $136.06
- AVG Volume (30 Days)
- ADBE 4.5M
- ABT 7.5M
- Earning Date
- ADBE 03-12-2025
- ABT 04-16-2025
- Dividend Yield
- ADBE N/A
- ABT 1.80%
- EPS Growth
- ADBE 44.74
- ABT 134.36
- EPS
- ADBE 15.16
- ABT 7.64
- Revenue
- ADBE $22,037,000,000.00
- ABT $41,950,000,000.00
- Revenue This Year
- ADBE $11.44
- ABT $6.72
- Revenue Next Year
- ADBE $10.12
- ABT $7.45
- P/E Ratio
- ADBE $25.43
- ABT $17.12
- Revenue Growth
- ADBE 10.54
- ABT 4.59
- 52 Week Low
- ADBE $374.50
- ABT $99.71
- 52 Week High
- ADBE $587.75
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- ADBE 35.42
- ABT 52.64
- Support Level
- ADBE $382.45
- ABT $124.50
- Resistance Level
- ADBE $404.50
- ABT $128.79
- Average True Range (ATR)
- ADBE 11.83
- ABT 2.83
- MACD
- ADBE -0.79
- ABT -0.20
- Stochastic Oscillator
- ADBE 16.15
- ABT 50.32
Stock Price Comparison Chart: ADBE vs ABT
About ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.